๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

[516] A RANDOMIZED TRIAL OF SWITCHING TO TELBIVUDINE VERSUS CONTINUED LAMIVUDINE IN ADULTS WITH CHRONIC HEPATITIS B: RESULTS OF THE PRIMARY ANALYSIS AT WEEK 24

โœ Scribed by R. Safadi; Q. Xie; Y. Chen; Y.-K. Yin; L. Wei; S.G. Hwang; E. Zuckerman; J.-D. Tia; G. Harb; N.A. Brown

Book ID
117375609
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
276 KB
Volume
46
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Telbivudine versus lamivudine in Chinese
Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial
โœ Jinlin Hou; You-Kuan Yin; Daozhen Xu; Deming Tan; Junqi Niu; Xiaqiu Zhou; Yuming ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 179 KB

Chronic hepatitis B and its life-threatening sequelae are highly prevalent in China. There is a need for effective new therapies to suppress hepatitis B virus (HBV) replication and ameliorate liver disease. In this study, we compared the efficacy of telbivudine, a nucleoside analogue, with lamivudin